Specificity of platinum–DNA adduct repair
- 1 October 1999
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 77 (1-2) , 71-81
- https://doi.org/10.1016/s0162-0134(99)00149-x
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Sequence- and Region-Specificity of Oxaliplatin Adducts in Naked and Cellular DNAMolecular Pharmacology, 1998
- Characterization of the Native and Recombinant Catalytic Subunit of Human DNA Polymerase γ: Identification of Residues Critical for Exonuclease Activity and Dideoxynucleotide SensitivityBiochemistry, 1998
- Decreased Drug Accumulation and Increased Tolerance to DNA Damage in Tumor Cells with a Low Level of Cisplatin ResistanceBiochemical Pharmacology, 1998
- Cross-Resistance, Cisplatin Accumulation, and Platinum–DNA Adduct Formation and Removal in Cisplatin-Sensitive and -Resistant Human Hepatoma Cell LinesExperimental Cell Research, 1996
- Thymine-Thymine Dimer Bypass by Yeast DNA Polymerase ζScience, 1996
- Cisplatin−DNA Binding Specificity of Calf High-Mobility Group 1 ProteinBiochemistry, 1996
- [11] Purification and domain-mapping of mammalian DNA polymerase βPublished by Elsevier ,1995
- Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell linesAnti-Cancer Drugs, 1993
- Nonclassical Platinum Antitumor Agents: Perspectives for Design and Development of New Drugs Complementary to CisplatinCancer Investigation, 1993
- DNA binding properties of [Pt(NH3)(C6H11NH2)Cl2], a metabolite of an orally active platinum anticancer drugJournal of the American Chemical Society, 1992